{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:44:21Z","timestamp":1791319461892,"version":"4.3.1"},"reference-count":43,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Int"],"DOI":"10.3892\/mi.2025.278","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:54:46Z","timestamp":1761288886000},"page":"1-9","source":"Crossref","is-referenced-by-count":5,"title":["Management of invasive candidiasis in the ICU: Challenges and advances (Review)"],"prefix":"10.3892","volume":"5","author":[{"given":"Wael","family":"Ghaly Elmasry","sequence":"first","affiliation":[{"name":"Department of Anesthesia, Mohammed Bin Rashid University of Medicine and Health Sciences and Intensive Care Unit, Rashid Hospital, Dubai, P.O. Box 4545, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mohamed Abdelbaky","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences and Intensive Care Unit, Rashid Hospital, Dubai, P.O. Box 4545, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Hossameldin","family":"Ahmed Awad","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences and Intensive Care Unit, Rashid Hospital, Dubai, P.O. Box 4545, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"key20251124134836_b1-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: Current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"key20251124134836_b2-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"key20251124134836_b3-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3390\/molecules19011085","article-title":"Invasive fungal infections in the ICU: How to approach, how to treat","volume":"19","author":"Paramythiotou","year":"2014","journal-title":"Molecules"},{"key":"key20251124134836_b4-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0040-1701215","article-title":"Invasive Candidiasis","volume":"41","author":"Gonzalez-Lara","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"key20251124134836_b5-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/MCC.0b013e32833e046e","article-title":"Pathogenesis of invasive candidiasis","volume":"16","author":"Van de Veerdonk","year":"2010","journal-title":"Curr Opin Crit Care"},{"key":"key20251124134836_b6-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.chest.2021.08.081","article-title":"Risk factors for invasive candida infection in critically Ill patients: A systematic review and meta-analysis","volume":"161","author":"Thomas-R\u00fcddel","year":"2022","journal-title":"Chest"},{"issue":"718","key":"key20251124134836_b7-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11060718","article-title":"Diagnosis and treatment of invasive candidiasis","volume":"11","author":"Barantsevich","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"key20251124134836_b8-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/14787210.2023.2240956","article-title":"Invasive Candida infection: Epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin","volume":"21","author":"Oliva","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key20251124134836_b9-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"e01909","DOI":"10.1128\/JCM.01909-17","article-title":"Diagnosing invasive candidiasis","volume":"56","author":"Clancy","year":"2018","journal-title":"J Clin Microbiol"},{"key":"key20251124134836_b10-MI-5-6-00278","first-page":"65","article-title":"Laboratory diagnosis of invasive candidiasis","volume":"43","author":"Ellepola","year":"2005","journal-title":"J Microbiol"},{"key":"key20251124134836_b11-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/aas.13783","article-title":"Use and outcome of empiric echinocandins in critically ill patients","volume":"65","author":"Ylipalosaari","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"issue":"97","key":"key20251124134836_b12-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/jof4030097","article-title":"Treatment of invasive candidiasis: A narrative review","volume":"4","author":"Ben-Ami","year":"2018","journal-title":"J Fungi (Basel)"},{"issue":"1351","key":"key20251124134836_b13-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01351","article-title":"Candida infections and therapeutic strategies: Mechanisms of action for traditional and alternative agents","volume":"9","author":"De Oliveira Santos","year":"2018","journal-title":"Front Microbiol"},{"key":"key20251124134836_b14-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key20251124134836_b15-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/QCO.0000000000000684","article-title":"Mind the gaps: Challenges in the clinical management of invasive candidiasis in critically ill patients","volume":"33","author":"Pe\u00e7anha-Pietrobom","year":"2020","journal-title":"Curr Opin Infect Dis"},{"issue":"165","key":"key20251124134836_b16-MI-5-6-00278","article-title":"Challenges in the diagnosis and treatment of invasive candidiasis in India","volume":"10","author":"Mehta","year":"2024","journal-title":"Int J Crit Care Emerg Med"},{"key":"key20251124134836_b17-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive candidiasis in critical care: Challenges and future directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med"},{"key":"key20251124134836_b18-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1515\/jccm-2015-0025","article-title":"Invasive candida infections in the ICU: Diagnosis and therapy","volume":"1","author":"Hankovszky","year":"2015","journal-title":"J Crit Care Med (Targu Mures)"},{"issue":"55","key":"key20251124134836_b19-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4710-z","article-title":"Antifungal resistance in patients with Candidaemia: A retrospective cohort study","volume":"20","author":"Aldardeer","year":"2020","journal-title":"BMC Infect Dis"},{"key":"key20251124134836_b20-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.cnc.2021.07.002","article-title":"Invasive fungal infections among immunocompromised patients in critical care settings: Infection prevention risk mitigation","volume":"33","author":"Mei-Sheng Riley","year":"2021","journal-title":"Crit Care Nurs Clin North Am"},{"key":"key20251124134836_b21-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"161","DOI":"10.4161\/viru.26187","article-title":"Invasive candidiasis as a cause of sepsis in the critically ill patient","volume":"5","author":"Delaloye","year":"2014","journal-title":"Virulence"},{"key":"key20251124134836_b22-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1128\/JCM.43.4.1829-1835.2005","article-title":"Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, barcelona, Spain, from 2002 to 2003","volume":"43","author":"Almirante","year":"2005","journal-title":"J Clin Microbiol"},{"key":"key20251124134836_b23-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-017-1042-z","article-title":"Pharmacokinetics of antifungal drugs: Practical implications for optimized treatment of patients","volume":"45","author":"Bellmann","year":"2017","journal-title":"Infection"},{"key":"key20251124134836_b24-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/jof1020217","article-title":"Application of Culture-independent rapid diagnostic tests in the management of invasive candidiasis and cryptococcosis","volume":"1","author":"Pfaller","year":"2015","journal-title":"J Fungi (Basel)"},{"issue":"244","key":"key20251124134836_b25-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1186\/cc9239","article-title":"Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit","volume":"14","author":"Bassetti","year":"2010","journal-title":"Crit Care"},{"issue":"a019653","key":"key20251124134836_b26-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019653","article-title":"Antifungal pharmacokinetics and pharmacodynamics","volume":"5","author":"Lepak","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"469","key":"key20251124134836_b27-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00469","article-title":"Immunomodulation for the treatment of fungal infections: Opportunities and challenges","volume":"10","author":"Ademe","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"key20251124134836_b28-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed9010008","article-title":"The impact of antifungal stewardship on clinical and performance measures: A global systematic review","volume":"9","author":"Alhamad","year":"2023","journal-title":"Trop Med Infect Dis"},{"key":"key20251124134836_b29-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"46","key":"key20251124134836_b30-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics13010046","article-title":"Multidrug-resistant sepsis: A critical healthcare challenge","volume":"13","author":"Kumar","year":"2024","journal-title":"Antibiotics (Basel)"},{"issue":"62","key":"key20251124134836_b31-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-023-01159-0","article-title":"Trends in ICU mortality and underlying risk over three decades among mechanically ventilated patients. A group level analysis of cohorts from infection prevention studies","volume":"13","author":"Hurley","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"ofac401","key":"key20251124134836_b32-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac401","article-title":"Machine learning in infectious disease for risk factor identification and hypothesis generation: Proof of concept using invasive candidiasis","volume":"9","author":"Mayer","year":"2022","journal-title":"Open Forum Infect"},{"issue":"29768675241304684","key":"key20251124134836_b33-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1177\/29768675241304684","article-title":"A Narrative review of invasive candidiasis in the intensive care unit","volume":"19","author":"Nopp\u00e8","year":"2024","journal-title":"Ther Adv Pulm Crit Care Med"},{"issue":"1207","key":"key20251124134836_b34-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/children11101207","article-title":"Recent challenges in diagnosis and treatment of invasive candidiasis in neonates","volume":"11","author":"Baltogianni","year":"2024","journal-title":"Children (Basel)"},{"issue":"447","key":"key20251124134836_b35-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/jof10070447","article-title":"Molecular diagnostics for invasive fungal diseases: Current and future approaches","volume":"10","author":"Pham","year":"2024","journal-title":"J Fungi (Basel)"},{"issue":"18026","key":"key20251124134836_b36-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.26","article-title":"Invasive candidiasis","volume":"4","author":"Pappas","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"60","key":"key20251124134836_b37-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0235-8","article-title":"Voriconazole and posaconazole therapeutic drug monitoring: A retrospective study","volume":"16","author":"Yi","year":"2017","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"key20251124134836_b38-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s15010-023-02078-9","article-title":"Posaconazole exposure in critically ill ICU patients: A need for action","volume":"51","author":"K\u00f6nig","year":"2023","journal-title":"Infection"},{"issue":"20499361231161387","key":"key20251124134836_b39-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.1177\/20499361231161387","article-title":"Flucytosine and its clinical usage","volume":"10","author":"Sigera","year":"2023","journal-title":"Ther Adv Infect Dis"},{"issue":"645","key":"key20251124134836_b40-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11050645","article-title":"Therapeutic drug monitoring of antifungal agents in critically Ill patients: Is there a need for dose optimisation?","volume":"11","author":"Baracaldo-Santamar\u00eda","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"1439586","key":"key20251124134836_b41-MI-5-6-00278","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1439586","article-title":"Voriconazole: A review of adjustment programs guided by therapeutic drug monitoring","volume":"15","author":"Jiang","year":"2024","journal-title":"Front Pharmacol"},{"key":"key20251124134836_b42-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1099\/0022-1317-51-5-433","article-title":"Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species","volume":"51","author":"Sendid","year":"2002","journal-title":"J Med Microbiol"},{"key":"key20251124134836_b43-MI-5-6-00278","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.diagmicrobio.2004.08.015","article-title":"Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies","volume":"51","author":"Prella","year":"2005","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Medicine International"],"original-title":[],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T11:48:44Z","timestamp":1763984924000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mi.2025.278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,10,24]]}},"URL":"https:\/\/doi.org\/10.3892\/mi.2025.278","relation":{},"ISSN":["2754-3242","2754-1304"],"issn-type":[{"value":"2754-3242","type":"print"},{"value":"2754-1304","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}